[1]
S. Hussain, N. Imtiaz, M. A. Amin, S. Khan, and S. Kakar, “COMPARISON OF TWO WIDELY USED ATYPICAL ANTIPSYCHOTICS OLANZAPINE VERSUS RISPERIDONE IN TERMS OF METABOLIC OUTCOMES”, PAFMJ, vol. 71, no. Suppl-1, pp. S147–52, Jan. 2021.